37942-76-0

Basic information

• Product Name: 4-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER
• Synonyms: 4-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER;Cyclohexanecarboxylic acid, 4-forMyl-, Methyl ester;4-forMylcyclohexanecarboxylic acid;4-(Methoxycarbonyl)cyclohexanecarboxaldehyde;METHYL 4-FORMYLCYCLOHEXANE-1-CARBOXYLATE
• CAS NO: 37942-76-0
• Molecular Formula: C₉H₁₄O₃
• Molecular Weight: 170.20566
• Mol File: 37942-76-0.mol

Chemical Properties

• Boiling Point: 236.4±33.0 °C(Predicted)
• Appearance: /
• Density: 1.129±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 4-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER(37942-76-0)
• EPA Substance Registry System: 4-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER(37942-76-0)

Safety Data

• Hazardous Substances Data: 37942-76-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
4-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER serves as a valuable reagent in organic synthesis, facilitating the creation of a wide range of chemical products. Its unique structure allows for various chemical transformations, making it a preferred choice for researchers and chemists in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER is utilized as a building block for the development of new pharmaceutical compounds. Its chemical properties enable it to be a component in the synthesis of drugs, contributing to the discovery and creation of novel therapeutic agents.
Used in Chemical Research:
4-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER is also employed in chemical research as a model compound to study reaction mechanisms and to develop new synthetic methodologies. Its reactivity and structural features make it an ideal candidate for exploring innovative approaches in chemical synthesis and understanding fundamental chemical processes.

Upstream product

• 79-37-8 oxalyl dichloride 
• 13380-85-3 4-hydroxymethylcyclohexanecarboxylic acid methyl ester 
• 67-68-5 dimethyl sulfoxide 
• 13380-84-2 4-(hydroxymethyl)cyclohexane-1-carboxylic acid 
• 6297-22-9 4-carbomethoxycyclohexanone 

Downstream Products

• 1383985-52-1 methyl 4-(difluoromethyl)cyclohexanecarboxylate 

Relevant articles and documents

LIQUID CRYSTAL COMPOUNDS OF BUTYLENES

A nematic phase liquid crystal compound with negative dielectric constant has a structure represented by wherein R1 represents a hydrogen atom or linear alkyl having 1 to 8 carbon atoms or linear alkenyl having 1-8 carbon atoms, or an alkoxy or alykenoxy

INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME

The present invention relates to compounds of formula (I): wherein R1, R2, and R3, are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.

Dioxane derivatives, liquid-crystal compositions containing the same, and liquid-crystal display devices made by using the same

The present invention provides liquid crystalline compounds having a high voltage holding ratio and a remarkably high Δε value, electric and chemical stability, and having good compatibility with known liquid crystalline compounds, liquid crystal compositions containing the compound, and liquid crystal display devices constituted by using the compounds. The liquid crystalline compounds of the present invention are particular dioxane derivatives represented by general formula (1). Further, the present invention relates to liquid crystal compositions characterized in that the compositions comprise at least one of the derivatives, and liquid crystal display devices constituted by using the compositions.

Pesticidal compounds

The present invention provides a class of novel substituted bicyclooctanes which have pesticidal activity, particularly against arthropod pests. Pesticidal formulations containing the compounds of the formula (I), their use in the control of pests and methods for their preparation are also disclosed.